🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with tirzepatide and fatty liver? Page 6

Has anyone dealt with tirzepatide and fatty liver?

Dr.PeteFamMed Tue, Nov 18, 2025 at 6:29 PM 39 replies 1,964 viewsPage 6 of 8
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Nov 27, 2025 at 12:04 AM#26
Dr.AddMedPHL said:
If you are going to change something, change one thing and give it long enough to express itself.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

34 9NauseaFreeNow, SteveThurs, B12Beth and 31 others
Reply Quote Save Share Report
emma_london
Member
312
1,456
Oct 2024
London, UK
Nov 27, 2025 at 11:46 PM#27
Dr.AddMedPHL said:
If you are going to change something, change one thing and give it long enough to express itself.

That holds where the measurement is reliable. Where it is noisy — and a lot of what gets tracked here is noisy — the same reasoning produces confident nonsense.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

33 8mike.trainer_LA, sarah_nash92, FitDadDave and 30 others
Reply Quote Save Share Report
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Nov 28, 2025 at 11:28 PM#28
Dr.AddMedPHL said:
If you are going to change something, change one thing and give it long enough to express itself.

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

32 7LibrarianMeg, bri_stats, pete_manc_UK and 29 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Nov 29, 2025 at 11:11 PM#29

Adding the clinical framing, because it changes how the question reads. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

31 6Dr.PulmRoch, maya_sedona, stefan_berlin and 28 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Nov 30, 2025 at 10:54 PM#30

OP back with an update, since a thread like this is useless without one.

Update — I was wrong in the opening post, specifically about the direction. Correcting it here rather than editing it away.

9 9FranDenver, Dr.BariatricHTX, LindaRN_retired and 6 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register